发明名称 |
IMMUNOTHERAPY |
摘要 |
The invention provides an agent comprising: a cyclic peptide comprising a T cell antigen peptide; wherein in cyclised form the T cell antigen peptide is not capable of eliciting a T cell response; and wherein the T cell antigen peptide is rendered capable of eliciting a T cell response by selective cleavage of one or more cleavage sites in the cyclic peptide. The agent may be used to prevent or treat a condition characterised by the presence of unwanted cells. |
申请公布号 |
WO2015001361(A1) |
申请公布日期 |
2015.01.08 |
申请号 |
WO2014GB52052 |
申请日期 |
2014.07.04 |
申请人 |
THE UNIVERSITY OF BIRMINGHAM |
发明人 |
COBBOLD, MARK;MILLAR, DAVID |
分类号 |
C07K7/64;A61K38/12;A61K39/12;A61K47/48;C07K14/045;C07K14/47 |
主分类号 |
C07K7/64 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|